BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23828664)

  • 1. Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide.
    Zhang MZ; Yu Y; Yu RN; Wan M; Zhang RY; Zhao YD
    Small; 2013 Dec; 9(24):4183-93. PubMed ID: 23828664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High transfection efficiency of quantum dot-antisense oligonucleotide nanoparticles in cancer cells through dual-receptor synergistic targeting.
    Zhang MZ; Li C; Fang BY; Yao MH; Ren QQ; Zhang L; Zhao YD
    Nanotechnology; 2014 Jun; 25(25):255102. PubMed ID: 24896735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional quantum-dot-based siRNA delivery for HPV18 E6 gene silence and intracellular imaging.
    Li JM; Zhao MX; Su H; Wang YY; Tan CP; Ji LN; Mao ZW
    Biomaterials; 2011 Nov; 32(31):7978-87. PubMed ID: 21784514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking.
    Li JM; Wang YY; Zhao MX; Tan CP; Li YQ; Le XY; Ji LN; Mao ZW
    Biomaterials; 2012 Mar; 33(9):2780-90. PubMed ID: 22243797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted quantum dots fluorescence probes functionalized with aptamer and peptide for transferrin receptor on tumor cells.
    Zhang MZ; Yu RN; Chen J; Ma ZY; Zhao YD
    Nanotechnology; 2012 Dec; 23(48):485104. PubMed ID: 23138109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow release and delivery of antisense oligonucleotide drug by self-assembled peptide amphiphile nanofibers.
    Bulut S; Erkal TS; Toksoz S; Tekinay AB; Tekinay T; Guler MO
    Biomacromolecules; 2011 Aug; 12(8):3007-14. PubMed ID: 21707109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of quantum dot nanoparticle cellular uptake.
    Zhang LW; Monteiro-Riviere NA
    Toxicol Sci; 2009 Jul; 110(1):138-55. PubMed ID: 19414515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional quantum dot-polypeptide hybrid nanogel for targeted imaging and drug delivery.
    Yang J; Yao MH; Wen L; Song JT; Zhang MZ; Zhao YD; Liu B
    Nanoscale; 2014 Oct; 6(19):11282-92. PubMed ID: 25130175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantum Dots in an Amphiphilic Polyethyleneimine Derivative Platform for Cellular Labeling, Targeting, Gene Delivery, and Ratiometric Oxygen Sensing.
    Park J; Lee J; Kwag J; Baek Y; Kim B; Yoon CJ; Bok S; Cho SH; Kim KH; Ahn GO; Kim S
    ACS Nano; 2015 Jun; 9(6):6511-21. PubMed ID: 26057729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted cellular uptake and siRNA silencing by quantum-dot nanoparticles coated with β-cyclodextrin coupled to amino acids.
    Zhao MX; Li JM; Du L; Tan CP; Xia Q; Mao ZW; Ji LN
    Chemistry; 2011 Apr; 17(18):5171-9. PubMed ID: 21465588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ; Marcucci G; Lee RJ
    Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-mediated intracellular delivery of quantum dots.
    Lagerholm BC
    Methods Mol Biol; 2007; 374():105-12. PubMed ID: 17237533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small and stable peptidic PEGylated quantum dots to target polyhistidine-tagged proteins with controlled stoichiometry.
    Dif A; Boulmedais F; Pinot M; Roullier V; Baudy-Floc'h M; Coquelle FM; Clarke S; Neveu P; Vignaux F; Le Borgne R; Dahan M; Gueroui Z; Marchi-Artzner V
    J Am Chem Soc; 2009 Oct; 131(41):14738-46. PubMed ID: 19788248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantum dot-antisense oligonucleotide conjugates for multifunctional gene transfection, mRNA regulation, and tracking of biological processes.
    Li Y; Duan X; Jing L; Yang C; Qiao R; Gao M
    Biomaterials; 2011 Mar; 32(7):1923-31. PubMed ID: 21145105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis.
    Lee H; Kim IK; Park TG
    Bioconjug Chem; 2010 Feb; 21(2):289-95. PubMed ID: 20078095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivering quantum dot-peptide bioconjugates to the cellular cytosol: escaping from the endolysosomal system.
    Delehanty JB; Bradburne CE; Boeneman K; Susumu K; Farrell D; Mei BC; Blanco-Canosa JB; Dawson G; Dawson PE; Mattoussi H; Medintz IL
    Integr Biol (Camb); 2010 Jun; 2(5-6):265-77. PubMed ID: 20535418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembly of folate onto polyethyleneimine-coated CdS/ZnS quantum dots for targeted turn-on fluorescence imaging of folate receptor overexpressed cancer cells.
    Zhang Y; Liu JM; Yan XP
    Anal Chem; 2013 Jan; 85(1):228-34. PubMed ID: 23194289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular delivery of quantum dot-protein cargos mediated by cell penetrating peptides.
    Medintz IL; Pons T; Delehanty JB; Susumu K; Brunel FM; Dawson PE; Mattoussi H
    Bioconjug Chem; 2008 Sep; 19(9):1785-95. PubMed ID: 18681468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
    Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
    Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.